Literature DB >> 1367398

Serum-free medium for murine and human lymphoid and hybridoma cell lines.

M Togami1, K Yasuda, M Kariya.   

Abstract

We established a serum-free medium of low protein content (125 micrograms/ml) TYI 100, consisting of three hormones and five growth factors for the growth of lymphoid and hybridoma cell lines. In TYI 100 medium, mouse and human hybridomas grew equally well as in RPMI 1640 supplemented with 10% fetal bovine serum (10% FBS) without adaptation to the serum-free medium. TYI 100 medium allowed several passages of mouse hybridoma lines and the total cell number was more than in 10% FBS. TYI 100 medium also supported growth of myelomas and anchorage dependent cell lines, Bowes and CHO, well. TYI 100 medium is composed of inexpensive supplements and is therefor applicable to large scale culture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367398     DOI: 10.1007/bf00353700

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  3 in total

1.  Serum-free media in hybridoma culture and monoclonal antibody production.

Authors:  M C Glassy; J P Tharakan; P C Chau
Journal:  Biotechnol Bioeng       Date:  1988-10-05       Impact factor: 4.530

2.  Serum-free cell culture: a unifying approach.

Authors:  D Barnes; G Sato
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

3.  Replacement of serum by hormones permits growth of cells in a defined medium.

Authors:  I Hayashi; G H Sato
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

  3 in total
  2 in total

1.  Carbohydrate and amino acid metabolism during batch culture of a human lymphoblastoid cell line, BTSN6.

Authors:  C P Marquis; J P Barford; C Harbour; A Fletcher
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

2.  Studies of serum-free medium for the generation of lymphokine-activated killer cells.

Authors:  M Togami; K Yasumoto; T Yano; T Ishida; G Kimura; K Sugimachi; K Nomoto
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.